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Abstract  
Context: This review discusses the range of clinical presentations seen with poisonings by the major toxic 
alcohols--methanol, ethylene glycol, and isopropyl alcohol. It outlines a straightforward diagnostic strategy 
and discusses in detail the current treatment recommendations.  
Evidence acquisition: The authors conducted a literature search of primary and secondary sources related to 
the topic. For treatment recommendations, search restrictions included articles published between 2008 and 
2019. For background information, search restrictions included articles written from 1990 – present.   
Results: This review discusses in detail how the diagnosis can be made via clinical signs, symptoms, and 
laboratory values as well as the most recent treatment recommendations. This paper will also discuss the 
limitations of the emergency department workup and how the absence of particular laboratory findings does 
not necessarily rule out the diagnosis.  
Conclusion: Poisoning with methanol, ethylene glycol, and isopropanol present diagnostic and therapeutic 
challenges to emergency physicians. Toxic alcohol poisonings lead to an elevated osmolar gap and, with the 
exception of Isopropanol, a metabolic acidosis. In order for the timely initiation of life-saving treatment, 
emergency physicians need a solid understanding of the pathophysiology, clinical presentation, laboratory 
workup, and treatment. 
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CONTEXT  
Poisonings with methanol, ethylene glycol, and 
isopropanol—commonly referred to as the toxic 
alcohols—often present the emergency physician 
with a major diagnostic challenge. The identity of 
the ingested substance is frequently a mystery on 
presentation. Patients with an intentional 
ingestion, either for recreation or with suicidal 
intent, may be less than forthcoming. Young 
patients may not be able to identify the substance. 
Patients may be in significant distress or comatose 
and unable to give any useful history. In these 
cases, the clinician must rely upon the nature of the 
presentation and the presence of metabolic 
derangements—and must always keep a high index 
of suspicion for toxic alcohol poisoning.  
Direct assays for the toxic alcohols are seldom 
available. The American College of Clinical 
Toxicology states that for toxic alcohol levels to be 
clinically useful, they must be resulted within two 
hours of being drawn (1). The gold standard test for 
the determination of serum toxic alcohol levels, 
however, is gas chromatography, which the vast 
majority of hospital labs do not have the capability 
of performing. This lab becomes a “send-out” and 
therefore useless in the acute setting.  
Because toxic alcohol poisoning may cause 
potentially irreversible damage in a time-
dependent fashion, prompt diagnosis and 
treatment are crucial (2). Though we lack 
immediate testing for the toxic alcohols, there are 
useful laboratory clues that can help clinicians 
quickly zero in on the most likely toxic agent. Those 
clues include the osmol gap, the anion gap, and the 
patient’s acid-base status. This article will review 
the pathophysiology of these intoxications, the 
clinical presentations, the laboratory workup, and 
the treatment of toxic alcohol ingestions. This 
paper will also discuss the limitations of the 
emergency department workup and how the 
absence of particular laboratory findings does not 
necessarily rule out the diagnosis. 
EVIDENCE ACQUISITION 
The authors conducted a literature search of 
primary and secondary sources related to the topic. 
For treatment recommendations, search 
restrictions included articles published between 
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2008 and 2019. For background information, 
search restrictions included articles written from 
1990 – present.  
RESULTS 
Toxic alcohols are found in many readily available 
household and industrial products. Methanol 
(“wood alcohol”) is a major component of 
windshield washer fluid, many industrial solvents, 
and may also be ingested as a recreational 
intoxicant sometimes mislabeled “moonshine”. 
Ethylene glycol is a chief component of antifreeze 
(3). Isopropanol, widely known as rubbing alcohol, 
is a common antiseptic (4). Although fatalities from 
toxic alcohol ingestions are relatively rare in the 
United States (< 30 per year), delayed diagnosis 
and treatment are the main reasons for poor 
outcomes (5). It cannot be over-stressed that early 
identification and treatment can significantly 
reduce morbidity and mortality. 
The toxicity of methanol and ethylene glycol arises 
primarily from highly toxic intermediate 
metabolites generated by the action of alcohol 
dehydrogenase (ADH), the key enzyme in their 
breakdown. The inhibition of ADH, therefore, 
becomes a crucial step in treatment (5). ADH 
catalyzes the first oxidation of methanol and 
ethylene glycol to formaldehyde and glycoaldehyde 
respectively. These compounds undergo further 
oxidation by aldehyde dehydrogenase (ALDH) to 
form carboxylic acid metabolites. Methanol is 
ultimately metabolized to formic acid, while 
ethylene glycol is metabolized to glycolic acid and 
oxalic acid (Figures 1, 2). These metabolic 
byproducts are potent organic acids that generate 
a high anion gap metabolic acidosis. They are also 
responsible, as further discussed below, for other 
significant toxic effects (1).  
Although methanol and ethylene glycol both 
produce CNS depression, isopropanol generates 
the most profound degree (1). Isopropanol is 
rapidly absorbed and inebriates much like ethanol. 
It is directly converted to acetone by alcohol 
dehydrogenase, and acetone itself is a CNS 
depressant that leads to further sedation (Figure 
3). Ingestions are sometime due to an attempt by 
 
Figure 1: The metabolic pathway of Methanol 
Figure 2: The metabolic pathway of Ethylene Glycol 
 
Figure 3: The metabolic pathway of Isopropanol 
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an individual to replace ethanol when it is 
unavailable. It does not undergo further 
metabolism beyond acetone, which is eliminated 
renally and via the lungs. Acetone, however, does 
not induce a metabolic acidosis (1). 
Methanol and ethylene glycol, therefore, will 
produce an increased osmol gap and a metabolic 
acidosis. Isopropanol, on the other hand, yields 
only an increased osmolar gap without metabolic 
acidosis. The clinician must keep in mind, however, 
that the presence of a metabolic acidosis does not 
completely preclude isopropanol ingestion; 
concomitant hypotension or the co-ingestion of 
additional agents may upset the acid/base balance 
and cloud the picture. One thing remains true: low 
molecular weight substances in the serum, such as 
these alcohols, ethanol included, will raise the 
measured serum osmolality above the calculated 
osmolality, producing an osmol gap (2, 6). Table 1 
shows stepwise approach to calculating the Osmol 
Gap.  
The anion gap is neither sensitive nor specific for 
diagnosing toxic alcohol poisoning. Soon after 
ingestion, the patient may manifest symptoms of 
toxic alcohol ingestion without an anion gap 
metabolic acidosis. The metabolic acidosis 
increases as the toxic alcohols are metabolized to 
organic acids (formate, oxalate). This creates an 
inverse relationship between the serum anion gap 
and osmol gap making the values time-dependent 
from ingestion, which is often unknown (Figure 4). 
In addition, the process of metabolism of toxic 
alcohols to organic acids can be slow. The half-life 
of methanol to formic acid is approximately 6 – 18 
hours with acidosis developing as late as 20 hours 
post ingestion (7). 
Like the anion gap, the osmol gap has low 
sensitivity and specificity for toxic alcohol 
poisoning. The range of “normal” for the osmol gap 
varies, typically see as < 10 to < 20 mOsm/L, 
depending upon source. The differential diagnosis 
for elevated osmol gap is wide as any osmotically 
active substance present in the blood can lead to 
higher than normal serum osmolality. Important, 
alternative etiologies include ketoacidosis 
(diabetic, alcoholic), acute renal failure, chronic 
renal disease, lactic acidosis, mannitol, and shock 
(8). These disorders usually have an osmol gap ≤ 15 
– 20 mOsm/L. Therefore, an osmol gap > 20 
mOsm/L is suspicious for the accumulation of toxic 
alcohols, especially if there is no other identified 
source. The absence of an osmol gap does not 
exclude toxic alcohol poisoning because blood-
alcohol levels that are sufficient to cause clinical 
abnormalities may not markedly elevate the osmol 
gap (2).  
Methanol  
Methanol is a colorless, volatile liquid at room 
temperature, possessing only a faint, sweet odor. 
Intoxications are rare (1000-2000 cases per year, 
 
Figure 4: The inverse relationship between anion and osmol 
gaps 
Table 1: Stepwise approach to calculating the Osmol Gap 
1. Determining the osmol gap begins with obtaining a measured serum osmolality from the laboratory. The normal measured 
serum osmolality is typically between 285 – 290 mOsm/L 
2. The calculated serum osmolality is then determined by the following equation: 
OSM calc (mOsm/L) =  (2 x Na⁺) + (BUN (mg/dL)/2.8) + (glucose (mg/dL)/18) 
3. When attempting to determine the osmolar gap, it is crucial to also check an ethanol level. Ethanol, like the other alcohols, is a 
low molecular weight substance that will also increase the osmolar gap, altering the results.  
4. Calculation of ethanol’s contribution to the serum osmolality is achieved with the following equation: 
OSM calc (mOsm/L) =  (2 x Na⁺) + (BUN (mg/dL)/2.8) + (glucose (mg/dL)/18) + (ethanol (mg/dL)/4.25) 
5. The osmol gap is measured as the difference between the calculated serum osmolality (OSM calc ) and the measured osmolality 
(OSM meas). The difference between the two should be less than or equal to 20 
OSM calc -  OSM meas = ≤ 20 mOsm/L 
6. Intoxication with methanol or ethylene glycol produce a high anion gap metabolic acidosis. The anion gap can be calculated 
with the following formula: 
Sodium – (chloride + bicarbonate) = 12 ± 4 
7. It is important to remember, isopropanol poisoning will cause an elevated osmol gap without a metabolic acidosis, 
making this calculation important in differentiating between possible intoxicants.  
 
ADVANCED JOURNAL OF EMERGENCY MEDICINE. 2019;3(3):e28 Gallagher et al 
   
 
4 Copyright © 2019 Tehran University of Medical Sciences  
This open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 License (CC BY-NC 4.0). 
 
about 1% of all significant poisonings) and occur 
primarily through the intentional or unintentional 
ingestion of methanol containing liquids including 
windshield washer fluid or antifreeze (2). Methanol 
has been used as an ethanol replacement and can 
be found in some products called “moonshine”. 
(Classic “moonshine” is a high-concentration 
ethanol solution distilled from fermented corn). 
Methanol is rapidly absorbed following ingestion 
and is metabolized by ADH. Toxicity has been 
reported with as little as 15 ml of 40% methanol 
solution, which is its approximate concentration in 
-30-degree F windshield washer fluid (2). Peak 
levels generally occur within 60-90 minutes (1). 
Methanol is processed in the body via zero-order 
kinetics in which a constant amount of drug is 
eliminated per unit time independent of the total 
body load. The estimated elimination of methanol 
is about 8.5 mg/dl per hour. ADH’s affinity for 
ethanol is 10 times greater than its affinity for 
methanol, making ethanol an effective competitive 
inhibitor that diminishes the conversion of 
methanol to its toxic metabolites (1). 
Formaldehyde and formic acid, the toxic 
metabolites of methanol metabolism, are 
extremely damaging to both the central nervous 
system and the gastrointestinal (GI) tract and 
generate a profound metabolic acidosis. Nausea, 
vomiting, and abdominal pain are common 
symptoms (9). With significant methanol 
poisonings the serum bicarbonate level can be 
extremely low. The optic nerve is especially 
susceptible to damage by formic acid, and visual 
disturbances occur in 29 – 72% of cases (10). These 
visual disturbances range from initial blurriness, to 
photophobia, altered visual fields and, if left 
untreated, eventual blindness (9). 
Clinical symptoms of methanol toxicity usually 
develop over 6-24 hours. This time course can be 
delayed if ethanol is co-ingested.10 Later in the 
course, a common triad of symptoms will usually 
be noticed (1): 
1. Visual disturbances (12-24 hours) 
2. GI bleeding, pancreatitis 
3. Metabolic acidosis  
The mainstay of treatment for methanol poisoning 
is twofold: 1) the prevention of metabolism; and 2) 
elimination from the body.10 Regarding the first 
factor, the American Academy of Clinical 
Toxicology (AACT) recommends that ethanol or 
fomepizole be given to block the metabolism of 
methanol based on the following set of criteria 
(11): 
1. Plasma methanol concentration > 20 mg/dl 
2. Recent history of ingestion of methanol with 
serum osmol gap > 10 mOsm/L  
3. Strong clinical suspicion of methanol poisoning 
with at least two of the following:  
 arterial pH < 7.3 
 serum HCO3 < 20 mEq/L 
 osmol gap > 20 mOsm/L  
Because ADH has a much greater affinity for 
ethanol than for methanol, it will preferentially 
bind to ethanol if available. This will disrupt the 
conversion of methanol to formaldehyde and 
formic acid. Maintaining an adequate and steady 
ethanol level in the blood (100-150 mg/dL) is 
critical for this method to be successful (1).  
The use of intravenous ethanol in the treatment of 
methanol poisoning has advantages and 
disadvantages. Ethanol is cheap, effective, and 
readily available. Conversely, administration of 
intravenous ethanol requires frequent monitoring 
of serum levels, risk for hypoglycemia, CNS 
depression, and need for close monitoring, 
preferably in an intensive care unit.10 Ethanol is 
also not an FDA approved method of treatment. 
Fomepizole is a competitive inhibitor of ADH that 
received FDA approval for the treatment of 
methanol poisoning in 2000 (2, 11). It is more 
commonly used now in the United States than 
ethanol. In 2015, 90-94% of cases of methanol 
poisoning were treated with fomepizole, versus 5-
6% treated with ethanol (10).  
ADH has an affinity for fomepizole up to 8000 times 
greater than that for ethanol. Fomepizole is 
effective at low concentrations, has a minimal side 
effect profile, and does not require frequent levels 
to be checked or close monitoring in the ICU (11). 
Initially, the cost of fomepizole was a limiting factor 
to its widespread adoption. The development of 
generic fomepizole has made treatment costs 
comparable to ethanol and have solidified it as the 
treatment of choice (5, 10). 
Since the development of fomepizole, there are 
mixed feelings among toxicologists concerning the 
use of hemodialysis in the removal of formic acid in 
methanol poisoning. A 2002 study by Kerns, et al. 
found little impact on the half-life of formic acid 
and concluded that, with low serum methanol 
levels, dialysis may provide little benefit (12, 13). 
Fomepizole has, in some cases, eliminated the need 
for emergent dialysis in patients with improving 
metabolic acidosis and a serum methanol 
concentration < 50 mg/dL, allowing it to be delayed 
until hours after admission (2). 
The Extracorporeal Treatments in Poisonings 
Workgroup (EXTRIP) has presented clear 
recommendations for the use of hemodialysis in 
severe methanol poisoning (14): 
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1. Coma, Seizures, New Vision Deficits 
2. Metabolic acidosis (blood pH ≤ 7.15) 
3. Persistent metabolic acidosis despite adequate 
supportive measures and antidotes 
4. Serum anion gap higher than 24 mmol/L 
5. Serum methanol concentration:  
a. greater than 70 mg/dL in the context of 
fomepizole therapy 
b. greater than 60 mg/dL in the context of 
ethanol treatment 
c. greater than 50 mg/dL in the absence of an 
alcohol dehydrogenase blocker 
6. Renal Failure 
Folate has also been shown to accelerate the 
conversion of formic acid to carbon dioxide and 
water, aiding in its elimination from the body (1, 9). 
Given folate’s low side effect profile, its 
administration should be considered in all 
methanol poisoned patients. The administration of 
base is recommended to treat the metabolic 
acidosis as it also aids in the renal removal of 
formic acid (2). Gastric decontamination with 
activated charcoal has limited, if any, value because 
methanol is rapidly absorbed within 30 minutes of 
ingestion. Gastric lavage is contraindicated for this 
same reason (1). 
Ethylene Glycol  
Ethylene glycol (EG) is a colorless, odorless liquid 
with a sweet taste. Most poisonings happen 
through oral ingestion of EG containing liquids, 
most commonly antifreeze. There are cases of EG 
poisonings from ethanol substitution, suicide 
attempts, and accidental ingestions (2, 15). EG 
intoxication is more common in the United States 
than methanol. A 2013 survey detailed a total of 
5,956 exposures (2% of all significant poisonings), 
2,314 of which required hospitalization, versus 
1,578 methanol poisonings, 616 of which required 
inpatient treatment) (5). These numbers have 
remained reasonably stable year to year.  
The mortality of EG poisonings varies greatly 
owing to the differences in amount ingested and 
time to treatment. The highest mortality is found in 
patients with the greatest degree of metabolic 
acidosis (pH < 7.1) and the longest time from 
exposure to initiation of treatment (> 10 hours.) 
(2). The lethal dosage of EG has been reported to be 
1.4 – 1.5 mg/kg body weight (about 100 mL in a 
70kg adult). Death has been shown at lower 
amounts, however, and survival at greater 
concentrations (2). Like methanol, EG is rapidly 
absorbed from the GI tract and peak serum 
concentrations are present within 1-2 hours of 
ingestion.  
EG is metabolized in a 2-step process by ADH and 
aldehyde dehydrogenase with first-order kinetics. 
In this mechanism, a constant proportion of the 
substance is eliminated per unit time and the rate 
of elimination is directly proportional to the 
amount of substance present. EG is first 
metabolized by ADH to glycoaldehyde, then to 
glycolic acid and oxalic acid by aldehyde 
dehydrogenase. Glycolic acid is the primary 
metabolite responsible for the severe metabolic 
acidosis seen with EG intoxications. Glycolic acid 
inhibits cellular respiration, which favors 
anaerobic metabolism and the production of lactic 
acid. 
Oxalic acid leads to the formation of calcium 
oxalate crystals. The accumulation of calcium 
oxalate crystals in the kidney may cause varying 
degrees of renal failure. The deposition of calcium 
oxalate in tissues, furthermore, can induce enough 
hypocalcemia to depresses cardiac output. Calcium 
oxalate will generally be detectable in the urine 
four to eight hours after ingestion (2). In the first 4-
5 hours, envelope-shaped, dihydrate crystals will 
be seen. At 5-7 hours, a combination of dihydrate 
crystals and needle shaped monohydrate crystals 
will appear. At greater than 7 hours, only 
monohydrate crystals typically remain (2). Based 
upon clinical suspicion of EG poisoning, the 
examination of urine sediment by light microscopy 
can aid in the diagnosis. However, this finding is 
neither highly sensitive nor specific as there are a 
number of other causes of calcium oxalate crystal 
formation, and the absence of crystals does not rule 
out the diagnosis.  
Some manufacturers of EG containing antifreeze 
add sodium fluorescein (SF) to the mixture for the 
purpose of allowing mechanics to visualize 
automotive coolant leaks during inspection (16). 
The examination of urine with a wood’s lamp has 
been suggested as a possible diagnostic tool in 
patients with suspected EG intoxication. There are 
several factors that decrease the usefulness of this 
testing adjunct. SF is present in a number of drugs, 
food products, and other toxins leading to false 
positive results (2). Also, not every brand of 
antifreeze adds SF to their product, creating false 
negatives. Additionally, SF has a short half-life of 
4.25 hours making its absence in the urine 
unreliable, especially with an unknown time of 
ingestion (2, 16, 17). 
There have been a number of studies examining the 
use of SF detection by wood’s lamp to aid in the 
diagnosis of EG poisoning. When testing 
physicians’ ability to detect SF by this method, a 
2001 study by Wallace et al showed a mean 
sensitivity, specificity, and accuracy for detecting 
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the presence of SF in urine to be 35%, 75%, and 
48% respectively (18). An additional study in 2005 
by Parsa et al showed that physicians in two 
separate groups were able to detect SF in urine 
under the influence of a Wood’s lamp in 80.7% 
(group 1) and 69.3% (group 2) of samples with 
poor inter-rater agreement (72.5%) (17). Given 
these data, physicians should be careful about 
confirming or excluding the diagnosis of EG toxicity 
based on this test, and it should never be used 
independently when making a decision about 
initiating treatment (2). 
Clinically, patients with ethylene glycol 
intoxication present with the following triad: 
1. Stage 1: Occurs 30 minutes to 12 hours after 
ingestion and is characterized by slurred speech, 
ataxia, anion gap-metabolic acidosis, proteinuria, 
hematuria, and CNS depression. 
2. Stage 2: Occurs 12 to 36 hours after ingestion and 
is characterized by symptoms including rapid 
respiration, cyanosis, and pulmonary edema. 
3. Stage 3: Occurs 2 to 3 days after ingestion and is 
characterized by renal insufficiency including 
proteinuria, oliguria, and anuria (1). 
The management strategy for EG poisoning is 
similar to that of methanol. Because its toxicity 
rests in the byproducts of metabolism (glycolic acid 
and oxalic acid), blocking this process is key. 
Fomepizole has a far greater affinity for ADH than 
does EG making it, again, a powerful competitive 
inhibitor of the enzyme. Ethanol can also be used to 
block ADH and is an effective therapy if fomepizole 
is not available. Gastric decontamination with 
charcoal is ineffective because of rapid absorption 
of EG via the GI tract (1). 
The American Academy of Clinical Toxicology 
(AACT) recommends that ethanol or fomepizole be 
given in the presence of the following clinical 
findings (2): 
1. Ethylene glycol level > 20 mg/dl or a 
documented history of ingestion of potentially 
toxic amounts of ethylene glycol 
2. Serum osmol gap > 10 mOsm/L  
3. Or a history or strong clinical suspicion of 
ethylene glycol poisoning and two of the following 
abnormalities:  
 Arterial pH < 7.3 
 Serum bicarbonate concentration < 20 mEq/L 
 Osmol gap > 10 mOsm/L 
 The presence of oxalate crystals in the urine 
Hemodialysis has been shown to be effective at 
removing ethylene glycol and glycolic acid from the 
system but like methanol poisoning, the role of 
dialysis is controversial (2, 19). Three studies from 
1986, 1998, and 2001 demonstrated the 
effectiveness of hemodialysis at removing both EG 
and glycolic acid with a mean clearance of about 
145-230 ml/min (2). This is extremely important 
as glycolic acid is largely responsible for the 
metabolic acidosis seen in EG intoxication and its 
levels correlate with prognosis and mortality.  
In contrast, investigations from 1999, 2001, and 
2010 question the use of hemodialysis, especially 
in uncomplicated patients treated with fomepizole, 
in spite of high EG levels (20-22). In particular, the 
1999 retrospective study by Borron et al looked at 
11 patients, 8 of which were treated with 
fomepizole alone. The patients without renal 
failure recovered without the use of hemodialysis 
(20). The AACT recommends dialysis for the 
treatment of EG poisoning when any of the 
following clinical factors are present: 1) Persistent 
metabolic acidosis (pH <7.25) despite therapy; 2) 
renal failure; 3) Ethylene glycol levels > 50 mg/dl. 
Because the serum concentration of glycolic acid 
has been shown to be an important prognostic sign, 
hemodialysis is also recommended if 
concentrations are 8 to 10 mmol/L (23). Glycolic 
acid levels are not readily available in a timely 
fashion in many laboratories. 
Isopropanol  
Isopropanol is a common substance found in 
cleaning agents and also marked as “rubbing 
alcohol,” a household antiseptic. It is the active 
component in “alcohol swabs” used in modern 
medicine. The majority of isopropanol exposures 
are unintentional and occur most commonly in 
children less than 6 years old (4). Other exposures 
have also been reported in suicide attempts and as 
an ethanol replacement (10). Poison control data 
from 1997, 1999, and 2004 showed a total of 
27,000 exposures making it more common than 
methanol and ethylene glycol. These exposures 
presented very low mortality (0.1% in 2004) (10). 
Isopropanol is absorbed much faster than ethanol 
making it roughly two times as intoxicating. An 
isopropanol level of 100 mg/dL can be considered 
equivalent to an ethanol level of 200 mg/dL (1). It 
is a powerful CNS depressant—as is its metabolic 
product, acetone. Its rapid conversion via ADH 
makes the time from ingestion to symptom onset 
within 30 minutes (1). Patients with isopropanol 
intoxication present with headache, dizziness, 
miotic pupils, stupor, or coma.  Isopropanol is a GI 
irritant and may cause abdominal pain, vomiting, 
diarrhea and hematemesis (1, 2). 
Acetone is primarily eliminated through the renal 
system with some escaping via the lungs. Acetone 
produces a “fruity” odor on the breath as seen in 
DKA.1 Most commonly, the patient with 
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isopropanol intoxication will present with an 
elevated osmolar gap without an acidosis (2). This 
is not always the case because high levels of 
isopropanol can cause hypotension leading to 
hypoperfusion and a lactic acidosis. The triad of 
normal acid-base status, hyperosmolality, and 
elevated acetone levels are very suggestive of the 
diagnosis (2). 
There are conflicting data with regard to 
blood/isopropanol levels and clinical outcomes. 
Some studies have suggested that levels of 150-200 
mg/dL can lead to increased mortality. Other 
studies have demonstrated only levels greater than 
400 mg/dL associated with poor outcomes (2). 
Management of isopropanol toxicity generally 
consists of supportive care. This includes airway 
management, IV fluids, and control of GI bleeding.1 
Hemodialysis has proven effective at removing 
isopropanol. Dialysis is a reasonable consideration 
in patients with an elevated isopropanol level (> 
200 mg/dL) and the presence of significant 
symptoms including coma and/or hypotension. 
DISCUSSION  
The emergency physician must maintain a high 
index of suspicion for patients presenting with an 
unknown intoxication. This review discusses in 
detail how the diagnosis can be made via clinical 
signs, symptoms, and laboratory values as well as 
the most recent treatment recommendations. This 
paper will also discuss the limitations of the 
emergency department workup and how the 
absence of particular laboratory findings does not 
necessarily rule out the diagnosis. 
In the United States, toxic alcohol poisonings are 
rare, but delays in treatment are associated with 
significant morbidity and mortality. This makes 
rapid laboratory assessment and diagnosis 
essential. Recognizing toxic alcohol poisoning is a 
challenging endeavor for the emergency physician. 
These patients typically receive their initial 
evaluation in the emergency department and may 
present with a host of nonspecific symptoms 
(abdominal pain, nausea, vomiting, headache, GI 
bleeding) and altered mental status, stupor, or 
coma. With the lack of an inexpensive and readily 
available diagnostic test to detect these intoxicants, 
a high index of suspicion should be maintained for 
any patient presenting with unexplained metabolic 
acidosis, acute renal failure, neurologic 
dysfunction, and an elevated osmol gap (2).  
As discussed above, the measurements of anion 
gap and osmol gap are not sensitive nor specific 
enough to definitively diagnose or rule out toxic 
alcohol poisoning. Treatment with ethanol, 
fomepizole, and/or dialysis may need to be started 
before a definitive diagnosis has been made. A clear 
understanding of the toxic alcohol 
pathophysiology, patient presentation, the 
usefulness and limitations of the laboratory 
workup, and treatment options will expedite the 
diagnosis and improve patient outcomes. 
Limitations 
The information presented in this review article 
was garnered from a range of literature published 
over several decades and included the most 
current and relevant papers available. Important 
limitations in the diagnosis and treatment of toxic 
alcohol poisonings discussed in the paper include 
the accuracy and reliability of the osmol gap as 
there is a wide array of accepted “normal” ranges.  
In addition, there is an inverse relationship 
between the osmol gap and the anion gap making 
time of ingestion important in the interpretation of 
these results.  Much of the workup for toxic alcohol 
poisoning is time-dependent from the time of 
ingestion and this is very often unknown. In 
addition, definitive assays for the detection of toxic 
alcohol ingestions are not immediately available at 
most institutions. Toxicology is a continually 
evolving field, however, and as new studies are 
reported, some of our conclusions may need 
revision. 
CONCLUSIONS 
Poisoning with methanol, ethylene glycol, and 
isopropanol present diagnostic and therapeutic 
challenges to emergency physicians. Toxic alcohol 
poisonings lead to an elevated osmolar gap and, with 
the exception of Isopropanol, a metabolic acidosis. In 
order for the timely initiation of life-saving 
treatment, emergency physicians need a solid 
understanding of the pathophysiology, clinical 
presentation, laboratory workup, and treatment. 
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